Search

everythinglearnresearchcommunity

for

Search:↓

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

Rheumatology clinics should always provide preconception counseling for women on DMARDs.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Nail loss may be a side effect of the MS drug teriflunomide.

Amitriptyline can cause temporary hair loss, which stops after discontinuing the drug.

Voriconazole can cause serious side effects, especially in long-term use.

Isotretinoin shrinks sebaceous glands without affecting hair or skin color, unlike etretinate.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

The ACP's migraine treatment guidelines are flawed and don't prioritize patient safety.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Oral alitretinoin is effective for certain types of chronic hand eczema, with mild side effects.

Biotin supplements increased biotin levels but did not significantly prevent hair loss in rats on valproic acid.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

The lemur's testicular tumor was removed, improving its coat and behavior, with no signs of cancer spread.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

Test liver enzymes and triglycerides every 5-6 months, and cholesterol levels in the first two months for acne patients on isotretinoin.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Interferon therapy improves quality of life for chronic hepatitis B patients.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Cannabidivarin (CBDV) may help brain cell growth and survival through the TRPV1 receptor.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.